The Pancreatic Cancer Therapy Market size was estimated to be US$ 2.81 billion in 2022 and US$ XX million in 2023 and is expected to reach US$ 6.47 billion by 2031; it is estimated to record a CAGR of 10.0% till 2031. The rapid adoption of combination therapy is likely to remain key Pancreatic Cancer Therapy Market trend.
Pancreatic Cancer Therapy Market Analysis
The increasing prevalence of pancreatic cancer, advancement in cancer treatment technologies, use of a combination of multiple treatments, insurance coverage of pancreatic therapy, and increasing support from the government for the treatment of cancer is fueling the growth of the pancreatic cancer therapy market. In addition, increasing product launches and investment in R&D for the development of cancer diagnostics and treatment is fueling the growth of the market.
Pancreatic Cancer Therapy Market Overview
India is among the countries that are emerging in terms of healthcare infrastructure and also in terms of diagnosis for several diseases. The prevalence of pancreatic cancer is rising and the cancer is initially undetected due to which the cancer spreads rapidly till it is detected. Due to rapid advancement in medical science and technology, cancer treatment in India is rapidly developing. There are many skilled oncologists in India who have treated pancreatic cancer due to which patients from various countries are coming to India for treatment. In, addition, much research is going on in the country for the development of various therapies for the treatment of pancreatic cancers. Thus increasing R&D activities for cancer treatment, increasing medical tourism due to the presence of a skilled workforce, and rapid advancement in healthcare institutions is fuelling the growth of the pancreatic cancer therapy market in India.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pancreatic Cancer Therapy Market: Strategic Insights
Market Size Value in US$ 2011.2 Million in 2017 Market Size Value by US$ 4056.4 Million by 2025 Growth rate CAGR of 8.1% from 2018-2025 Forecast Period 2018-2025 Base Year 2018
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pancreatic Cancer Therapy Market: Strategic Insights
| Market Size Value in | US$ 2011.2 Million in 2017 |
| Market Size Value by | US$ 4056.4 Million by 2025 |
| Growth rate | CAGR of 8.1% from 2018-2025 |
| Forecast Period | 2018-2025 |
| Base Year | 2018 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pancreatic Cancer Therapy Market Drivers and Opportunities
Increasing Burden of Pancreatic Cancer
Pancreatic cancer is one of the aggressive cancers that originates in the in the tissues of pancreas and rapidly spreads to the nearby organs. Despite rapid developments in medical technology and improvements in survival rates of other cancers, pancreatic cancer is still a highly lethal cancer with a low 5-year survival rate and difficulty in early detection. As per the World Cancer Research Fund International, pancreatic cancer is the 12th most common cancer worldwide. As per the same source, in 2020, ~495,000 new cases of pancreatic cancer were diagnosed globally. There is a steady increase in incidence and mortality rate due to pancreatic cancer in people aged above 40 years. According to the estimated by American Cancer Society, about 66,440 people in the US will be diagnosed with pancreatic cancer in 2024 and ~51,750 people in the US will die due to pancreatic cancer. As per American Society of Clinical Oncology, in 2023, ~64,050 people in the US were diagnosed with pancreatic cancer. Thus, the increasing prevalence of pancreatic cancer is fuelling the growth of the pancreatic cancer therapy market.
Development of Immunotherapy– An Opportunity for Pancreatic Cancer Therapy Market
There are various rapid advancements in the therapy type used for the treatment of pancreatic cancer. Immunotherapy is a new therapy type which is used to treat other cancer types such as lymphoma, breast cancer, and leukemia. There are studies going on to check the efficacy of immunotherapy, especially T-cells in the treatment of pancreatic cancer. Pancreatic Cancer has shown the presence of tumor-infiltrating lymphocytes (TILs) due to which the T-cell therapy has demonstrated positive result in the treatment of solid tumors such as pancreatic cancer. Thus, ongoing research for the use of immunotherapy for the treatment of pancreatic cancer creates growth opportunities for the pancreatic cancer therapy market.
Pancreatic Cancer Therapy Market Report Segmentation Analysis
Key segments that contributed to the derivation of the Pancreatic Cancer Therapy Market analysis are solutions, mode of delivery, application, and end user.
- Based on type, the Pancreatic Cancer Therapy Market is segmented into endocrine pancreatic cancer and exocrine pancreatic cancer. The exocrine pancreatic cancer segment held a larger market share in 2023.
- By therapy, the Pancreatic Cancer Therapy Market is segmented into biologic therapy, chemotherapy, and others. The biologic therapy segment held the largest market share in 2023.
Pancreatic Cancer Therapy Market Share Analysis by Geography
The geographic scope of the Pancreatic Cancer Therapy Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the Pancreatic Cancer Therapy Market. The demand for the market in the region is anticipated to witness growth at a significant rate during the forecast period owing to various factors such as, rising prevalence of pancreatic cancer, a growing aging population in the region, and the presence of key players. Furthermore, the US government is opting for creating awareness about pancreatic cancer and extensive investment in R&D in the field of cancer treatment is likely to influence the pancreatic cancer therapy market. Also, improved insurance coverage for the treatment of cancer and awareness about early detection of pancreatic cancer is fueling the growth of the pancreatic cancer therapy market.
Pancreatic Cancer Therapy Market Report Scope
Pancreatic Cancer Therapy Market News and Recent Developments
The Pancreatic Cancer Therapy Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for neurointerventional devices and strategies:
- Focal Medical received the US Food and Drug Administration (FDA) clearance for its investigational new drug application for ACT-IOP-003. ACT-IOP-003 is a pancreatic cancer drug in Phase 1b of clinical trial. ACT-IOP-003 is an implantable iontophoretic product that deliver high levels of gemcitabine directly to the pancreas. (Source: Verdict Media Limited, Press Release, 2024)
- The FDA approved irinotecan liposome (Onivyde) with oxaliplatin, fluorouracil, and leucovorin, for the first-line treatment of metastatic pancreatic adenocarcinoma. The drug Onivyde is manufactured by Ipsen Biopharmaceuticals Inc. (Source: FDA, Press Release, 2024)
Pancreatic Cancer Therapy Market Report Coverage and Deliverables
The “Pancreatic Cancer Therapy Market Size and Forecast (2023–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type , Therapy and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Pancreatic Cancer Therapy Market
May 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
May 2024
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
May 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
May 2024
Electronic Patient-Reported Outcomes (ePROS) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Wellbeing Platform Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Wellbeing, and Others), Category (Fitness & Nutrition Consultant, Psychological Therapists, and Organization/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organization, and Homecare), and Geography
May 2024
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Get Free Sample For